Can Handgrip Training Improve Nerve Conduction With Age?

Muscle strength can fade long before a person notices a dramatic loss of muscle size. Part of that decline may begin upstream, where motor nerves activate muscle fibers. Motor nerve conduction velocity (NCV) offers a measurable look at that system, yet it rarely appears beside grip strength, gait speed, or body-composition scans in longevity tracking.

A small randomized trial gives that omission a reason for a second look. After four weeks of handgrip training, both younger and older adults improved motor NCV, while control groups did not show statistically significant change. The result is intriguing, especially because the effect sizes were similar across ages. It does not establish handgrip exercise as a proven way to preserve nerves, prevent falls, or reverse neuromuscular aging. It does show that conduction velocity may respond to training more readily than the usual story of irreversible neural decline would suggest.

The aging problem is partly neural

Sarcopenia is often framed as a muscle problem: less muscle tissue, less force, less independence. That framing is incomplete. A 2025 systematic review by Cui et al. describes age-related motor-unit loss as a central feature of neuromuscular aging. A motor unit consists of one motor neuron and the muscle fibers it controls. As units are lost, surviving neurons can sprout new branches and reinnervate abandoned fibers. That compensation can preserve force for a while, but it creates fewer, larger motor units and does not fully replace the original system.

The losses appear to affect fast-twitch, type II fibers preferentially. Those fibers contribute disproportionately to rapid force production: catching yourself during a stumble, rising quickly from a chair, or stepping over a curb without turning it into a negotiation. The review also catalogs changes at the neuromuscular junction (NMJ), the tiny synapse between nerve and muscle: endplate fragmentation, fewer junctional folds, lower acetylcholine-receptor density, and retraction of terminal Schwann cells. Together, these changes could make neuromuscular transmission less reliable.

Electromyography (EMG) can detect parts of this process before ordinary strength tests identify clinical weakness. Motor unit number estimation (MUNE) and the motor unit number index (MUNIX) estimate motor-unit loss and remodeling. A 2022 review by Verschueren et al. describes both as tools for tracking the denervation-and-reinnervation cycle in aging. They are useful research measures, not consumer wearables, and they answer a different question than NCV. MUNE and MUNIX estimate motor-unit number and remodeling; NCV measures how quickly an electrical signal travels along a peripheral nerve.

What four weeks of handgrip training changed

The direct exercise evidence comes from a 2025 randomized controlled trial by Shields et al. The study enrolled 48 people ages 18 to 84 and assigned younger and older participants to training or control groups. Each training subgroup had 14 participants. Researchers measured motor NCV before and after a four-week handgrip-training intervention.

NCV rose significantly in both training groups. The younger training group had Cohen's d = 0.749, P < 0.001; the older training group had d = 0.679, P < 0.001. The young control group had d = 0.326, P = 0.353, so its change was not statistically significant. The available report does not provide a corresponding control result for the older group beyond the fact that neither control group reached significance.

The similar training-group effect sizes are the most interesting part of the experiment. They provide preliminary evidence that older participants can show a change in this conduction measure over a short training period. But a difference of about 0.07 in effect size between the younger and older groups was not reported as a formal between-group test. With 14 people per training subgroup, sampling noise could easily account for a difference that small.

More important, the trial reports standardized effects and P values, not the absolute NCV values in meters per second. Statistical significance tells us the observed change was unlikely under the study's null model; it does not tell us whether the change was large enough to affect strength, mobility, fall risk, symptoms, or daily function. NCV is a surrogate measure here, not a patient-centered outcome.

Why inactivity makes the result biologically plausible

Exercise did not need to be magic for this finding to make biological sense. A 2026 experimental pilot study by Motanova et al. found morphological and functional NMJ instability after 10 days of bed rest in older adults. Bed rest is an extreme model of inactivity, and the study did not measure NCV. It therefore cannot serve as the inverse of the handgrip trial or prove that exercise repairs the changes caused by disuse.

It does establish a narrower, useful point: the nerve-muscle interface responds to mechanical demand over days rather than simply ticking down on a fixed schedule. That makes a training effect plausible. It does not identify the pathway behind the NCV result. The change could reflect peripheral neural remodeling, altered Schwann-cell support, NMJ transmission, circulation, muscle temperature, or a measurement-related factor. The current human evidence cannot distinguish among them.

The human NMJ story remains unsettled

Rodent research has strongly shaped the view that aging fragments the NMJ. Human evidence is thinner and less tidy. Cui et al. note that a direct human histology study by Jones et al. found NMJs remarkably stable across the lifespan, with minimal age-related remodeling. That finding conflicts with a simple story of universal structural NMJ breakdown in healthy human aging.

It is not a clean dismissal of the broader framework. The control tissue in the Jones study came from limb amputations rather than a healthy control population, which complicates interpretation. Still, the disagreement matters. Human electrophysiology supports progressive motor-unit loss and compensatory reinnervation, but researchers have not settled how closely the structural NMJ changes seen in rodents map onto healthy humans.

Where the handgrip trial falls short

Five limitations keep this result in the "watch closely" category.

• Small age-stratified groups: 14 participants per training subgroup cannot provide a reliable answer about whether age changes the response.
• No absolute NCV values: Without meters-per-second values before and after training, clinical importance cannot be judged.
• Possible test-retest effects: The young control group's non-significant d = 0.326 suggests repeated testing or measurement conditions may contribute to apparent improvement.
• Short follow-up: Four weeks, with no later assessment, cannot show whether the change persists or reflects a temporary physiological state.
• Narrow intervention: Handgrip training targets the forearm. The study does not show that lower-limb nerves, compound lifts, resistance machines, or aerobic training produce the same effect.

The broader case for resistance training does not depend on this NCV result. A 2022 systematic review and meta-analysis by Mende et al. evaluated progressive machine-based resistance training in the oldest old and found chair-stand time was predominantly reduced, while grip strength remained unchanged after the interventions. A 2022 review of systematic reviews by Ferreira et al. evaluated exercise programs against sarcopenia criteria in older adults. A 2025 meta-analysis by Hernandez-Martinez et al. reported improvements in skeletal muscle mass index and maximal isometric handgrip strength among older adults with osteosarcopenia. Those findings support resistance training for strength, function, and muscle-related outcomes; they do not demonstrate an NCV mechanism.

What to do with this now

Keep resistance training in the plan because the evidence for muscle and functional benefits is much larger than the evidence for NCV. A simple grip routine may also be a practical way to build hand strength, but one small four-week trial cannot turn it into a validated neural-maintenance protocol.

For people pursuing clinical neuromuscular assessment, NCV, MUNE, and MUNIX may offer earlier signals than strength testing alone. They require trained clinicians, standardized conditions, and careful interpretation; they are not general-purpose screening tests to chase without a reason. The research question worth following is concrete: can larger, longer trials report absolute NCV changes, test lower-limb and multi-joint training, and show that any neural signal predicts better function? Until then, the handgrip result is a promising measurement finding, not a prescription rewrite.